Overview

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to investigate whether changes in lipids and hormonal parameters can be observed in blood when Carbamazepine treatment is replaced with Lacosamide treatment, while Levetiracetam treatment remains unchanged.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Carbamazepine
Etiracetam
Lacosamide
Levetiracetam
Piracetam